220 related articles for article (PubMed ID: 20951505)
1. Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery.
Vaidya JS; Baum M; Tobias JS; Wenz F; Massarut S; Keshtgar M; Hilaris B; Saunders C; Williams NR; Brew-Graves C; Corica T; Roncadin M; Kraus-Tiefenbacher U; Sütterlin M; Bulsara M; Joseph D
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1091-7. PubMed ID: 20951505
[TBL] [Abstract][Full Text] [Related]
2. Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost.
Vaidya JS; Baum M; Tobias JS; Massarut S; Wenz F; Murphy O; Hilaris B; Houghton J; Saunders C; Corica T; Roncadin M; Kraus-Tiefenbacher U; Melchaert F; Keshtgar M; Sainsbury R; Douek M; Harrison E; Thompson A; Joseph D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1335-8. PubMed ID: 17084562
[TBL] [Abstract][Full Text] [Related]
3. An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial).
Vaidya JS; Wenz F; Bulsara M; Tobias JS; Joseph DJ; Saunders C; Brew-Graves C; Potyka I; Morris S; Vaidya HJ; Williams NR; Baum M
Health Technol Assess; 2016 Sep; 20(73):1-188. PubMed ID: 27689969
[TBL] [Abstract][Full Text] [Related]
4. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger HL; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph DJ; Tobias JS
BMJ; 2020 Aug; 370():m2836. PubMed ID: 32816842
[TBL] [Abstract][Full Text] [Related]
5. Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer.
Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Bulsara M; Vaidya JS; Liedtke C
Rev Recent Clin Trials; 2017; 12(2):93-100. PubMed ID: 28155607
[TBL] [Abstract][Full Text] [Related]
6. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.
Vaidya JS; Wenz F; Bulsara M; Tobias JS; Joseph DJ; Keshtgar M; Flyger HL; Massarut S; Alvarado M; Saunders C; Eiermann W; Metaxas M; Sperk E; Sütterlin M; Brown D; Esserman L; Roncadin M; Thompson A; Dewar JA; Holtveg HM; Pigorsch S; Falzon M; Harris E; Matthews A; Brew-Graves C; Potyka I; Corica T; Williams NR; Baum M;
Lancet; 2014 Feb; 383(9917):603-13. PubMed ID: 24224997
[TBL] [Abstract][Full Text] [Related]
7. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
Vaidya JS; Joseph DJ; Tobias JS; Bulsara M; Wenz F; Saunders C; Alvarado M; Flyger HL; Massarut S; Eiermann W; Keshtgar M; Dewar J; Kraus-Tiefenbacher U; Sütterlin M; Esserman L; Holtveg HM; Roncadin M; Pigorsch S; Metaxas M; Falzon M; Matthews A; Corica T; Williams NR; Baum M
Lancet; 2010 Jul; 376(9735):91-102. PubMed ID: 20570343
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative radiotherapy (IORT) for breast cancer using the Intrabeam system.
Kraus-Tiefenbacher U; Scheda A; Steil V; Hermann B; Kehrer T; Bauer L; Melchert F; Wenz F
Tumori; 2005; 91(4):339-45. PubMed ID: 16277101
[TBL] [Abstract][Full Text] [Related]
9. IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study.
Ciabattoni A; Gregucci F; Fastner G; Cavuto S; Spera A; Drago S; Ziegler I; Mirri MA; Consorti R; Sedlmayer F
Breast Cancer Res; 2021 Apr; 23(1):46. PubMed ID: 33849606
[TBL] [Abstract][Full Text] [Related]
10. Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast Cancer.
Vaidya JS; Bulsara M; Saunders C; Flyger H; Tobias JS; Corica T; Massarut S; Wenz F; Pigorsch S; Alvarado M; Douek M; Eiermann W; Brew-Graves C; Williams N; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Baum M; Joseph D
JAMA Oncol; 2020 Jul; 6(7):e200249. PubMed ID: 32239210
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.
Veronesi U; Orecchia R; Maisonneuve P; Viale G; Rotmensz N; Sangalli C; Luini A; Veronesi P; Galimberti V; Zurrida S; Leonardi MC; Lazzari R; Cattani F; Gentilini O; Intra M; Caldarella P; Ballardini B
Lancet Oncol; 2013 Dec; 14(13):1269-77. PubMed ID: 24225155
[TBL] [Abstract][Full Text] [Related]
12. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
13. IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis.
Fastner G; Sedlmayer F; Merz F; Deutschmann H; Reitsamer R; Menzel C; Stierle C; Farmini A; Fischer T; Ciabattoni A; Mirri A; Hager E; Reinartz G; Lemanski C; Orecchia R; Valentini V
Radiother Oncol; 2013 Aug; 108(2):279-86. PubMed ID: 23830467
[TBL] [Abstract][Full Text] [Related]
14. Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy.
Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Liedtke C; Bulsara M; Vaidya JS
Strahlenther Onkol; 2017 Jan; 193(1):62-69. PubMed ID: 27858093
[TBL] [Abstract][Full Text] [Related]
15. The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer.
Vaidya JS; Baum M; Tobias JS; Morgan S; D'Souza D
Eur J Surg Oncol; 2002 Jun; 28(4):447-54. PubMed ID: 12099658
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage X-rays: the first 5 years of experience with a novel approach.
Wenz F; Welzel G; Blank E; Hermann B; Steil V; Sütterlin M; Kraus-Tiefenbacher U
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1309-14. PubMed ID: 20100643
[TBL] [Abstract][Full Text] [Related]
17. Targeted intraoperative radiotherapy for breast cancer in patients in whom external beam radiation is not possible.
Keshtgar MR; Vaidya JS; Tobias JS; Wenz F; Joseph D; Stacey C; Metaxas MG; Keller A; Corica T; Williams NR; Baum M
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):31-8. PubMed ID: 20646864
[TBL] [Abstract][Full Text] [Related]
18. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.
Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger H; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Blanc-Onfroy ML; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McReady D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph D; Tobias JS
Br J Cancer; 2021 Aug; 125(3):380-389. PubMed ID: 34035435
[TBL] [Abstract][Full Text] [Related]
19. Targeted Intraoperative Radiotherapy During Breast-conserving Surgery for Breast Cancer in Patients After Implant Augmentation.
Kolberg HC; Uhl V; Massarut S; Holmes D; Kolberg-Liedtke C; Kelly EW; Lövey G; Vaidya JS
Anticancer Res; 2019 Aug; 39(8):4215-4218. PubMed ID: 31366508
[TBL] [Abstract][Full Text] [Related]
20. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.
Poortmans PM; Collette L; Bartelink H; Struikmans H; Van den Bogaert WF; Fourquet A; Jager JJ; Hoogenraad W; Müller RP; Dubois JB; Bolla M; Van Der Hulst M; Wárlám-Rodenhuis CC; Pierart M; Horiot JC;
Cancer Radiother; 2008 Nov; 12(6-7):565-70. PubMed ID: 18760649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]